Irreversible Inactivation of Glutathione Peroxidase 1 and Reversible Inactivation of Peroxiredoxin II by H <sub>2</sub> O <sub>2</sub> in Red Blood Cells

書誌事項

公開日
2010-06
権利情報
  • https://creativecommons.org/licenses/by/4.0/
  • https://journals.sagepub.com/page/policies/text-and-data-mining-license
DOI
  • 10.1089/ars.2009.2701
公開者
SAGE Publications

この論文をさがす

説明

<jats:p> Catalase, glutathione peroxidase1 (GPx1), and peroxiredoxin (Prx) II are the principal enzymes responsible for peroxide elimination in RBC. We have now evaluated the relative roles of these enzymes by studying inactivation of GPx1 and Prx II in human RBCs. Mass spectrometry revealed that treatment of GPx1 with H <jats:sub>2</jats:sub> O <jats:sub>2</jats:sub> converts the selenocysteine residue at its active site to dehydroalanine (DHA). We developed a blot method for detection of DHA-containing proteins, with which we observed that the amount of DHA-containing GPx1 increases with increasing RBC density, which is correlated with increasing RBC age. Given that the conversion of selenocysteine to DHA is irreversible, the content of DHA-GPx1 in each RBC likely reflects total oxidative stress experienced by the cell during its lifetime. Prx II is inactivated by occasional hyperoxidation of its catalytic cysteine to cysteine sulfinic acid during catalysis. We believe that the activity of sulfiredoxin in RBCs is sufficient to counteract the hyperoxidation of Prx II that occurs in the presence of the basal level of H <jats:sub>2</jats:sub> O <jats:sub>2</jats:sub> flux resulting from hemoglobin autoxidation. If the H <jats:sub>2</jats:sub> O <jats:sub>2</jats:sub> flux is increased above the basal level, however, the sulfinic Prx II begins to accumulate. In the presence of an increased H <jats:sub>2</jats:sub> O <jats:sub>2</jats:sub> flux, inhibition of catalase accelerated the accumulation of sulfinic Prx II, indicative of the protective role of catalase. <jats:italic toggle="yes">Antioxid. Redox Signal.</jats:italic> 12, 1235–1246. </jats:p>

収録刊行物

被引用文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ